Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 tesla scanner

Investigative Radiology

Volumn 44, Issue 8, 2009, Pages 469-475

  Sadick, Maliha ^a   Schock, Daniel ^a   Kraenzlin, Bettina ^a   Gretz, Norbert ^a   Schoenberg, Stefan O ^a   Michaely, Henrik J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

2 compartment model; 3.0 Tesla scanner; Contrast enhanced MR imaging; Pcy mouse; Renal perfusion

Indexed keywords

CREATININE; GADOBUTROL; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; FEASIBILITY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; IMAGE ANALYSIS; IMAGE QUALITY; INTERNAL JUGULAR VEIN; INTRAVENOUS CATHETER; KIDNEY CORTEX; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; MORPHOLOGY; MOUSE; NEPHRONOPHTHISIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGIST; UREA BLOOD LEVEL;

EID: 68449085758     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181a8afa1     Document Type: Article

References (54)

1. Grenier N, Basseau F, Ries M, et al. Functional MRI of the kidney. Abdom Imaging. 2003;28:164-175.
2. Dujardin M, Sourbron S, Luypaert R, et al. Quantification of renal perfusion and function on a voxel-by-voxel basis: feasibility study. Magn Reson Med. 2005;54:841-849.
3. Hermoye L, Annet L, Lemmerling PH, et al. Calculation of the renal perfusion and glomerular filtration rate from the renal impulse response obtained with MRI. Magn Reson Med. 2004;51:1017-1025.
4. Michaely H, Sourbron S, Dietrich O, et al. Functional renal MR imaging: an overview. Abdom Imaging. In press.
5. Florijn KW, Chang PC, Woude van der FJ, et al. Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation. Transplantation. 1994;57:73-81.
6. Hovind P, Rossing P, Tarnow L, et al. Progression of diabetic nephropathy. Kidney Int. 2001;59:702-709.
7. Sansoé G, Silvano S, Mengozzi G, et al. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis. J Hepatol. 2004;40:417-423.
8. Soares CM, Oliveira EA, Diniz JS, et al. Predictive factors of progression of chronic renal insufficiency: a multivariate analysis. Pediatr Nephrol. 2003; 18:371-377.
9. Baumann D, Rudin M. Quantitative assessment of rat kidney function by measuring the clearance of the contrast agent Gd (DOTA) using dynamic MRI. Magn Reson Imaging. 2000;18:587-595.
10. Kobayashi H, Kawamoto S, Brechbiel MW, et al. Micro-MRI methods to detect renal cysts in mice. Kidney Int. 2004;65:1511-1516.
11. Towner RA, Yamaguchi T, Philbrick DJ, et al. In vivo proton manetic resonance imaging and localized spectroscopic analysis of polycystic kidney disease in DBA/2FG-pcy-mice. Magn Reson Imaging. 1991;9:429-434.
12. Cirillo M, Anastasio P, De Santo NG. Relationship of gender, age, and body mass index to errors in predicted kidney function. Nephrol Dial Transplant. 2005;20:1791-1798.
13. Qi Z, Whitt I, Mehta A, et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol. 2004;286:590-596.
14. Kassirer JP. Clinical evaluation of kidney function - glomerular function. N Engl J Med. 1971;285:385-389.
15. Rehberg PB. Studies on kidney function: the rate of filtration and reabsorption in the human kidney. Biochem J. 1926;20:447-460.
16. Frennby B, Sterner G. Contrast media as markers of GFR. Eur Radiol. 2002;12:475-484.
17. Pill J, Kloetzer HM, Issaeva O, et al. Direct fluorometric analysis of a newly synthesised fluorescein-labeled marker for glomerular filtration rate. Anal Bioanal Chem. 2005;382:59-64.
18. Elwood CM, Sigman EM, Treger C. The measurement of GFR with 125I-sodium iothalamate. Br J Radiol. 1967;40:778-782.
19. Rahn KH, Heidenreich S, Bruckner D. How to assess glomerular function and damage in humans. J Hypertens. 1999;17:309-317.
20. Almen T. Contrast agent design. Some aspects on the synthesis of water soluble contrast agents of low osmolarity. J Theor Biol. 1969;24:216-226.
21. Sohtell M, Karlmark B, Ulfendahl H. FITC-inulin as a kidney tubule marker in the rat. Acta Physiol Scand. 1983;119:313-316.
22. Doolan PD, Alpen EL, Theil GB. A clinical appraisal of the plasma concentration and endogenous clearance of creatinine. Am J Med. 1962;32:65-79.
23. Guder WG, Hoffmann GE. Multicentre evaluation of an enzymatic method for creatinine determination using a sensitive colour reagent. J Clin Chem Clin Biochem. 1986;24:889-902.
24. Rosano TG, Ambrose RT, Wu AHB, et al. Candidate reference method for determining creatinine in serum: method development and interlaboratory validation. Clin Chem. 1990;36:1951-1955.
25. Runge VM, Case RS, Sonnier HL. Advances in clinical 3-Tesla neuroimaging. Invest Radiol. 2006;41:63-67.
26. Allkemper T, Heindel W, Kooijmann H, et al. Effect of field strengths on magnetic resonance angiography. Invest Radiol. 2006;41:97-104.
27. Kramer U, Kambiz N, Laub G, et al. High-resolution magnetic resonance angiography of the renal arteries using parallel imaging acquisition techniques at 3.0 Tesla. Invest Radiol. 2006;41:125-132.
28. Michaely HJ, Sourbron SP, Buettner C, et al. Temporal constraints in renal perfusion imaging with a 2-compartment model. Invest Radiol. 2008;43:120-128.
29. Michaely HJ, Schoenberg SO, Oesingmann N, et al. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements-feasibility study. Radiology. 2006;238:586-596.
30. Sourbron SP, Michaely HJ, Raiser MF, et al. MR-renal perfusion and filtration measurement with a two-compartment model. Invest Radiol. 2008; 43:40-48.
31. VE Torres. Therapies to slow polycystic kidney disease. Exp Nephrol. 2004;98:1-7.
32. Manton P, Ichikawa I, Anagram T, et al. Renal physiology of the mouse. Am J Physiol Renal Physiol. 2000;476:339-351.
33. Okada H, Ban S, Nagao S, et al. Progressive renal fibrosis in marine polycystic kidney disease: an immunohistochemical observation. Kidney Int. 2000;58:587-597.
34. Sourbron S, Luypaert R, Van Schuerbeek P, et al. Deconvolution of dynamic contrast-enhanced MRI data by linear inversion: choice of the regularization parameter. Magn Reson Med. 2004;52:209-213.
35. Dujardin M, Luypaert R, Vandenbroucke F, et al. Combined T1-based perfusion MRI and MR angiography in kidney: first experience in normals and pathology. EJR. In press.
36. Dujardin M, Luypaert R, Sourbron S, et al. Age dependence of T1 perfusion MRI-based hemodynamic parameters in human kidneys. J Magn Reson Imaging. 2009;29:398-403.
37. Sourbron SP, Michaely HJ, Reiser MF, et al. MRI-Measurement of perfusion and glomerular filtration in the human kidney with a separable compartment model. Invest Radiol. 2008;43:40-48.
38. Attenberger UI, Sourbron SP, Notohamiprodjo M, et al. MR-based semiautomated quantification of renal functional parameters with a two-compartment model - an interobserver analysis. Eur J Radiol. 2008;65:59-65.
39. Bokacheva L, Rusinek H, Zhang JL, Chen Q, Lee VS. Estimates of GFR from MR renography and tracer kinetic models. J Magn Reson Imaging. 2009;29: 371-382.
40. Fenchel M, Nael K, Seeger A, et al. Whole-body magnetic resonance angiography at 3.0 Tesla. Eur Radiol. 2008;18:1473-1483.
41. Martirosian P, Boss A, Deimling M, et al. Systematic variation of off-resonance prepulses for clinical magnetization transfer contrast imaging at 0.2, 1.5, and 3.0 tesla. Invest Radiol. 2008;43:16-26.
42. Ludemann L, Nafz B, Elsner F, et al. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent. Invest Radiol. In press.
43. Fischer PA, Bogoliuk CB, Ramirez AJ, et al. A new procedure for evaluation of renal function without urine collection in rat. Kidney Int. 2000;58:1336-1341.
44. Noonan WT, Banks RO. Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus. Diabetes Res Clin Pract. 2000;225:221-230.
45. Lim RP, Shapiro M, Wang EY, et al. 3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced bolus-chase MRA and 3D time-of-flight MRA. Am J Neurodiol. 2008;29:1847-1854.
46. Niendorf ER, Grist TM, Lee FT, et al. Rapid in vivo measurement of single-kidney extraction fraction and glomerular filtration rate with MR imaging. Radiology. 1998;206:791-798.
47. Lee VS, Rusinek H, Noz ME, et al. Dynamic three-dimensional MR renography for the measurement of single kidney function: initial experience. Radiology. 2003;227:289-294.
48. Dunn SR, Qi Z, Bottinger E, et al. Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int. 2004;65:1959-1967.
49. Takahashi N, Boysen G, Li F, et al. Tandem mass spectrometry measurements of creatinine in mouse plasma and urine for determining glomerular filtration rate. Kidney Int. 2007;71:266-271.
50. Sällstrom J, Carlsson PO, Fredhol BB, et al. Diabetes-induced hyperfiltration in adenosine A(1)-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol. 2007;190:253-259.
51. Hackbarth H, Hackbarth D. Genetic analysis of renal function in mice: glomerular filtration rate and its correlation with body and kidney weight. Lab Anim. 1981;15:267-272.
52. Luippold G, Pech B, Schneider S, et al. Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice. Naunyn-Schmiedeberg's Arch Pharmacol. 2006;372:284-290.
53. Tchekneva E, Rinchik EM, Polosukhina D, et al. A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predis-posed to diabetic nephropathy. J Am Soc Nephrol. 2006;18:103-112.
54. Wallace D, Huang Z, Nivens E, et al. Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging. Kidney Int. 2008; 73:778-781.